Vapotherm Inc.

NYSE: VAPO · Real-Time Price · USD
2.17
-0.01 (-0.46%)
At close: Sep 19, 2024, 9:20 PM

Company Description

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally.

The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.

It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors.

In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range.

The company sells its products to hospitals.

Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Vapotherm Inc.
Vapotherm Inc. logo
Country United States
IPO Date Nov 14, 2018
Industry Medical - Devices
Sector Healthcare
Employees 182
CEO Joseph F. Army CPA

Contact Details

Address:
100 Domain Drive
Exeter, New Hampshire
United States
Website https://www.vapotherm.com

Stock Details

Ticker Symbol VAPO
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001253176
CUSIP Number 922107107
ISIN Number IE0003LFZ4U7
Employer ID 00-0000000
SIC Code 3841

Key Executives

Name Position
Joseph F. Army CPA Chief Executive Officer, President & Director
Brian Lawrence Senior Vice President & Chief Technology Officer
John Landry Senior Vice President, Chief Financial Officer & Treasurer
Anthony Ten Haagen Vice President of Legal & Compliance
Dorota Mckay Vice President, Controller & Chief Accounting Officer
Dr. Jessica Whittle M.D., Ph.D. Chief Medical Officer & Vice President of Clinical Research
James A. Lightman Senior Vice President, General Counsel & Secretary
Lindsay Becker Vice President of Human Resources
William Niland Founder

Latest SEC Filings

Date Type Title
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 14, 2024 SCHEDULE 13G Filing
Nov 14, 2024 SCHEDULE 13G/A [Amend] Filing
Nov 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Sep 25, 2024 15-12G Filing
Sep 24, 2024 SC 13D/A [Amend] Filing
Sep 24, 2024 4 Filing
Sep 24, 2024 4 Filing